Solensia 1mL Vial

  PRESCRIPTION MEDICATION - RX Required

Solensia is a cutting-edge, FDA-approved injectable solution designed to provide long-lasting pain relief for cats suffering from osteoarthritis (OA). Utilizing frunevetmab, a monoclonal antibody that targets nerve growth factor (NGF), Solensia effectively reduces pain and inflammation, improving the quality of life for your feline companion. This monthly treatment is specifically formulated to manage the chronic pain associated with OA, ensuring your cat can enjoy a more comfortable and active lifestyle.

Key Features:

• Long-Lasting Pain Relief: Provides up to one month of relief from osteoarthritis pain.
• Targeted Therapy: Utilizes frunevetmab, a monoclonal antibody that specifically targets and inhibits NGF.
• Improves Quality of Life: Reduces pain and inflammation, helping cats regain mobility and comfort.
• Convenient Monthly Injection: Simple, once-a-month administration by a veterinarian.
• Safe and Effective: FDA-approved with minimal side effects.

Indications:

Management of pain associated with osteoarthritis in cats.

Dosage and Administration:

• Solensia is administered as a subcutaneous injection once a month
• Dosage is based on the cat's weight:
  • Cats weighing 2.5 kg to 7.5 kg: Administer 1 mL (one vial) of Solensia.
  • Cats weighing more than 7.5 kg: Administer 2 mL (two vials) of Solensia.

Active Ingredient: Frunevetmab

Caution:

• For veterinary use only.
• Not for use in cats with known hypersensitivity to frunevetmab.
• Use with caution in cats with a history of severe allergic reactions.
• Always consult with your veterinarian before starting any new treatment.